What is the appropriate management plan for a 69‑year‑old woman with worsening right shoulder/upper‑arm pain of three weeks' duration, esophagitis and non‑erosive gastritis after a recent upper endoscopy, persistent gastroesophageal reflux disease symptoms, bilateral cataracts causing night‑driving difficulty, hair shedding, concerns about polypharmacy, and a first dose of recombinant zoster vaccine, including medication adjustments, referrals, and timing of the second vaccine dose?

Management Plan for 69-Year-Old Woman with Multiple Conditions

This patient requires continuation of PPI therapy for documented esophagitis and gastritis, immediate referral to ophthalmology for cataracts, evaluation for cervical radiculopathy or rotator cuff pathology for her shoulder pain, and completion of her recombinant zoster vaccine series at 2-6 months after the first dose.

Gastrointestinal Management

PPI Therapy Must Continue

This patient should NOT be considered for PPI de-prescribing given her recent endoscopy findings of esophagitis and non-erosive gastritis. 1 The AGA guidelines explicitly state that patients with documented erosive esophagitis should generally not be considered for PPI discontinuation 1. Her endoscopy revealed erythema and granularity throughout the esophagus compatible with esophagitis, plus gastritis—these are definitive indications for ongoing acid suppression therapy.

Key management points:

• Continue current PPI (or initiate if not already on one) at standard once-daily dosing
• PPIs achieve 75-95% healing rates for esophagitis after 8 weeks 2
• Her persistent epigastric discomfort with eating suggests ongoing inflammation requiring treatment
• The fundic polyp requires no specific intervention but should be monitored on future endoscopies

Addressing Polypharmacy Concerns

While she's concerned about medication burden, her current regimen (metformin, Zetia, PPI) is appropriate:

• Do not discontinue the PPI—this has a clear indication 1
• Metformin and Zetia are appropriate for diabetes and hyperlipidemia management
• Her previous statin intolerance justifies the Zetia use
• This is not excessive polypharmacy; each medication has a documented indication

Shoulder Pain Evaluation and Management

Likely Diagnosis: Cervical Radiculopathy vs. Rotator Cuff Pathology

Her presentation suggests either:

1. Cervical radiculopathy (nocturnal shock-like pain radiating down arm, bilateral involvement)
2. Degenerative rotator cuff tear (age 69, previous episode requiring PT, limitation with movement)

Immediate steps:

• Perform cervical spine range of motion testing and Spurling's test to assess for radiculopathy
• Conduct rotator cuff examination: empty can test, external rotation lag sign, liftoff test, belly press test 3
• Assess for impingement with Neer's and Hawkins' signs 3
• Order cervical spine X-rays and shoulder X-rays bilaterally
• Consider MRI of cervical spine if radiculopathy suspected, or shoulder MRI if rotator cuff tear likely

Treatment approach:

• Refer to physical therapy—this helped her previously and is first-line for both conditions
• NSAIDs if not contraindicated (consider GI protection given her esophagitis/gastritis)
• If cervical radiculopathy confirmed, consider neurology or spine referral
• If rotator cuff tear confirmed, consider orthopedic referral, especially if full-thickness tear

Ophthalmology Referral

Refer immediately to ophthalmology for cataract evaluation. Her bilateral cataracts causing night-driving difficulty represent a safety concern and functional impairment affecting quality of life. Cataract surgery has excellent outcomes and will significantly improve her vision and driving safety.

Zoster Vaccine Completion

Schedule the second dose of recombinant zoster vaccine (Shingrix) for 2-6 months after her first dose. 4 The FDA-approved dosing schedule for immunocompetent adults aged ≥50 years is:

• First dose at Month 0 (already completed)
• Second dose at 2-6 months later 4

Important points:

• She is NOT immunocompromised, so the standard 2-6 month interval applies (not the accelerated 1-2 month schedule) 4
• Both doses are required for optimal protection against herpes zoster
• The vaccine can be given concomitantly with influenza or pneumococcal vaccines if needed 4
• Common side effects include injection site pain (78%), myalgia (45%), fatigue (45%), and headache (38%) 4

Additional Considerations

Hair Shedding

• Assess thyroid function (TSH, free T4) given her age and symptoms
• Check ferritin, vitamin D, and B12 levels
• Consider telogen effluvium from stress or metabolic factors
• If workup negative, reassure that some hair thinning is age-related

Frequent Bathroom Urgency

• Likely related to metformin (common GI side effect)
• Could also be related to gastritis/esophagitis
• Monitor after esophagitis heals; if persistent, consider metformin formulation change (extended-release) or alternative diabetes medication

Follow-Up Plan

Schedule 8-week follow-up to:

• Reassess GI symptoms on PPI therapy
• Review imaging results for shoulder/cervical spine
• Check response to physical therapy
• Review thyroid and nutritional labs
• Ensure ophthalmology appointment scheduled
• Confirm second Shingrix dose scheduled at appropriate interval